Immunotherapy for Early-stage Gastric Cancer
‘Practice-changing’ research shows adding immunotherapy before and after surgery reduced recurrences for early-stage gastric cancer.
Progress Against Cancer
‘Practice-changing’ research shows adding immunotherapy before and after surgery reduced recurrences for early-stage gastric cancer.
Participating in a structured exercise program after treatment was associated with a reduced risk of recurrence in people who had colon cancer.
A single-cell atlas helped clarify diverse forms of acute myeloid leukemia, with potential implications for improving diagnostic, prognostic, and therapeutic capabilities.
Low-dose aspirin reduces cancer risk for people with Lynch syndrome, and breast cancer survivors may have lower risk for Alzheimer’s than the general public.
For June 2025, the editors of AACR's journals highlighted studies on pancreatic cancer interception, breast cancer risk prediction, and more.
A study suggests that modifying a patient’s gut microbiome could make their cancer more likely to respond to CAR T-cell therapy.
Surgery to remove fallopian tubes can lower ovarian cancer risk, and NIH staff cuts lead to delays for patients with no other treatment options.
Several new studies show how exercise can extend cancer patients’ survival, reduce the risk of recurrence, and improve quality of life.
Researchers explore the causes of lung cancer in never-smokers, and findings support start to colonoscopy screening at age 45.
This month, the editors of AACR’s journals picked studies highlighting genetic parallels between cancer evolution and high-altitude physiology, data linking oil and gas exposure to childhood leukemia risk, and more.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More